The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of June 2019. This month there are three guidelines and one technology appraisal that impact upon primary care.
The Urinary incontinence and pelvic organ prolapse in women guideline has been updated. It covers assessing and managing urinary incontinence and pelvic organ prolapse in women aged 18 and over. It also covers complications associated with mesh surgery for these conditions. Two recommendations on the use of synthetic polypropylene or biological mesh insertion for women with recurrent anterior vaginal wall prolapse have been withdrawn.
The Hypertension in pregnancy guideline has been published; it replaces previous guidance. It covers diagnosing and managing hypertension (high blood pressure), including pre-eclampsia, during pregnancy, labour and birth. It also includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension. It aims to improve care during pregnancy, labour and birth for women and their babies.
The Depression in children and young people guideline has been published; it replaces previous guidance. It covers identifying and managing depression in children and young people aged 5 to 18 years. Based on the stepped-care model, it aims to improve recognition and assessment and promote effective treatments for mild and moderate to severe depression.
The Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes technology appraisal has been published. Ertugliflozin is recommended as an option for treating type 2 diabetes in adults when diet and exercise alone do not provide adequate glycaemic control, only if:
- the disease is uncontrolled with metformin and a DPP‑4 inhibitor, and
- a sulfonylurea or pioglitazone is not appropriate.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.